Other
Share Repurchase Program, Remaining Authorized, Amount
Vertex Pharmaceuticals Share Repurchase Program, Remaining Authorized, Amount decreased by 14.3% to $3.00B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 211.1%, from $964.40M to $3.00B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026May 5, 2026
How to read this metric
A high remaining balance indicates potential future support for the stock price through buybacks.
Detailed definition
This is the portion of the board-authorized share repurchase program that has not yet been executed. It indicates the re...
Peer comparison
Used by investors to gauge the near-term potential for share count reduction and capital return.
Metric ID:
other_stock_repurchase_program_remaining_authorized_repu_889179Historical Data
10 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.90B | $2.80B | $2.70B | $2.40B | $2.10B | $1.80B | $964.40M | $4.60B | $3.50B | $3.00B |
| QoQ Change | — | -3.4% | -3.6% | -11.1% | -12.5% | -14.3% | -46.4% | +377.0% | -23.9% | -14.3% |
| YoY Change | — | — | — | -17.2% | -25.0% | -33.3% | -59.8% | +119.0% | +94.4% | +211.1% |
Range$964.40M – $4.60B
CAGR+1.5%
Avg YoY Growth+41.3%
Median YoY Growth-17.2%
Current Streak2 quarters decline
Share Repurchase Program, Remaining Authorized, Amount at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's share repurchase program, remaining authorized, amount?
- Vertex Pharmaceuticals (VRTX) reported share repurchase program, remaining authorized, amount of $3.00B in Q1 2026.
- How has Vertex Pharmaceuticals's share repurchase program, remaining authorized, amount changed year-over-year?
- Vertex Pharmaceuticals's share repurchase program, remaining authorized, amount increased by 211.1% year-over-year, from $964.40M to $3.00B.
- What does share repurchase program, remaining authorized, amount mean?
- The dollar amount of the share repurchase program that is still available to be used.